The Clinical Significance of Statistical Significance

Author:

Kane Robert C.1

Affiliation:

1. Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Abstract

Abstract Learning Objectives After completing this course, the reader should be able to: Explain the difference between exploratory (hypothesis-generating) analyses and confirmatory (hypothesis-testing) analyses.Describe why a statistical test result (p-value) only expresses the likelihood that the result could have occurred by chance and does not prove the truth of the study.Define what a hazard ratio expresses. CME This article is available for continuing medical education credit at CME.TheOncologist.com Modern clinical trials provide the evidence for most therapeutic advances, and that evidence, expressed in a statistical format, is used to draw inferences about a population from the study's results. Clinician judgment translates these inferences for best individual patient care, but many clinicians struggle with the statistical interpretation of trial results. This review provides a clinical and non-Bayesian perspective on some key elements in the statistical design, analysis, and interpretation of randomized, comparative, phase III clinical trials intended to demonstrate a better outcome (superiority) than with a control treatment.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference9 articles.

1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). E9 Statistical Principles for Clinical Trials. Available at http://www.ich.org/cache/compo/276-254-1.html. Accessed online September 10, 2008.

2. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684;Kirkwood;J Clin Oncol,1996

3. Treatment of resected non-small-cell lung cancer;Bria;N Engl J Med,2005

4. Adjuvant chemotherapy in completely resected non-small-cell lung cancer;Pisters;J Clin Oncol,2005

5. Gefitinib versus vinorelbine in chemotherapy-naïve elderly patients with advanced non-small-cell lung cancer (INVITE): A randomized, phase II study;Crino;J Clin Oncol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3